French health authorities suspend use of Valneva's chikungunya vaccine in older adults to probe 3 hospitalizations, one death
France’s public health agency has temporarily suspended the use of Valneva’s vaccine Ixchiq in adults ages 65 years and older as authorities investigate several serious adverse events experienced by elderly people during an ongoing vaccination campaign on the French islands of La Reunion and Mayotte.
France’s public health agency has temporarily suspended the use of Valneva’s vaccine Ixchiq in adults ages 65 years and older as authorities investigate several serious adverse events experienced by elderly people during an ongoing vaccination campaign on the French islands of La Reunion and Mayotte.
